community-acquired infections

Susceptibility
Antimicrobial Activities of Ceftaroline and ME1036 Tested against Clinical Strains of Community-Acquired Methicillin-Resistant Staphylococcus aureus
Helio S. Sader, Thomas R. Fritsche, Ronald N. Jones
Mechanisms of Resistance
Novel Characteristics of Community-Acquired Methicillin-Resistant Staphylococcus aureus Strains Belonging to Multilocus Sequence Type 59 in Taiwan
Tomomi Takano, Wataru Higuchi, Taketo Otsuka, Tatiana Baranovich, Shymaa Enany, Kohei Saito, Hirokazu Isobe, Soshi Dohmae, Kyoko Ozaki, Misao Takano, Yasuhisa Iwao, Michiko Shibuya, Takeshi Okubo, Shizuka Yabe, Da Shi, Ivan Reva, Lee-Jene Teng, Tatsuo Yamamoto
LETTERS TO THE EDITOR
Community-Acquired Liver Abscess Caused by Serotype K1 Klebsiella pneumoniae with CTX-M-15-Type Extended-Spectrum β-Lactamase
Sheng-Chiang Su, L. K. Siu, Ling Ma, Kuo-Ming Yeh, Chang-Phone Fung, Jung-Chung Lin, Feng-Yee Chang
Mechanisms of Resistance
Increased Macrolide Resistance of Mycoplasma pneumoniae in Pediatric Patients with Community-Acquired Pneumonia
Miyuki Morozumi, Satoshi Iwata, Keiko Hasegawa, Naoko Chiba, Reiko Takayanagi, Keita Matsubara, Eiichi Nakayama, Keisuke Sunakawa, Kimiko Ubukata
and the Acute Respiratory Diseases Study Group
Susceptibility
National and Regional Assessment of Antimicrobial Resistance among Community-Acquired Respiratory Tract Pathogens Identified in a 2005-2006 U.S. Faropenem Surveillance Study
Ian A. Critchley, Steven D. Brown, Maria M. Traczewski, Glenn S. Tillotson, Nebojsa Janjic
Clinical Therapeutics
Randomized, Double-Blind, Placebo-Controlled Trial of Cephalexin for Treatment of Uncomplicated Skin Abscesses in a Population at Risk for Community-Acquired Methicillin-Resistant Staphylococcus aureus Infection
Priya M. Rajendran, David Young, Toby Maurer, Henry Chambers, Francoise Perdreau-Remington, Peter Ro, Hobart Harris
Clinical Therapeutics
Comparison of β-Lactam and Macrolide Combination Therapy versus Fluoroquinolone Monotherapy in Hospitalized Veterans Affairs Patients with Community-Acquired Pneumonia
Thomas P. Lodise, Andrea Kwa, Leon Cosler, Reetu Gupta, Raymond P. Smith
Clinical Therapeutics
Health Care-Associated Pneumonia and Community-Acquired Pneumonia: a Single-Center Experience
Scott T. Micek, Katherine E. Kollef, Richard M. Reichley, Nareg Roubinian, Marin H. Kollef
Clinical Therapeutics
Targeted Intranasal Mupirocin To Prevent Colonization and Infection by Community-Associated Methicillin-Resistant Staphylococcus aureus Strains in Soldiers: a Cluster Randomized Controlled Trial
Michael W. Ellis, Matthew E. Griffith, David P. Dooley, Joseph C. McLean, James H. Jorgensen, Jan E. Patterson, Kepler A. Davis, Joshua S. Hawley, Jason A. Regules, Robert G. Rivard, Paula J. Gray, Julia M. Ceremuga, Mary A. DeJoseph, Duane R. Hospenthal
Clinical Therapeutics
Tetracyclines as an Oral Treatment Option for Patients with Community Onset Skin and Soft Tissue Infections Caused by Methicillin-Resistant Staphylococcus aureus
Jörg J. Ruhe, Anupama Menon

Pages